Travere Therapeutics (TVTX) Inventory (2014 - 2026)
Travere Therapeutics (TVTX) posted Inventory of $6.4 million for Q1 2026, up 8.19% on a QoQ basis from $5.9 million in Q4 2025, and up 61.65% year-over-year from $3.9 million in Q1 2025.
Travere Therapeutics (TVTX) Inventory (2014 - 2026) Analysis & Trends
Travere Therapeutics' Inventory history runs 13 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- Quarterly Inventory rose 61.65% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (up 61.65% YoY) and the FY2025 annual result came in at $5.9 million, down 5.24% from the prior year.
- Inventory was $6.4 million for Q1 2026 at Travere Therapeutics, up from $5.9 million in the prior quarter.
- Across five years, Inventory topped out at $20.8 million in Q3 2023 and bottomed at $3.9 million in Q1 2025.
- A 5-year average of $7.7 million and a median of $6.4 million in 2024 frame the typical range for Inventory.
- Annual changes were most pronounced in 2023 — Inventory jumped 184.68% — and 2024, when it sank 69.4%.
- Travere Therapeutics' Inventory stood at $4.5 million in 2022, then soared by 108.05% to $9.4 million in 2023, then sank by 34.11% to $6.2 million in 2024, then dropped by 5.24% to $5.9 million in 2025, then rose by 8.19% to $6.4 million in 2026.
- Business Quant data shows TVTX's Inventory at $6.4 million in Q1 2026, $5.9 million in Q4 2025, and $5.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 681.59 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.77 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.10 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 371.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | 6.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.36 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Sep 30, 2025 | 5.55 Mn |
| Jun 30, 2025 | 4.09 Mn |
| Mar 31, 2025 | 3.93 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Sep 30, 2024 | 6.36 Mn |
| Jun 30, 2024 | 5.98 Mn |
| Mar 31, 2024 | 4.53 Mn |
| Dec 31, 2023 | 9.41 Mn |
| Sep 30, 2023 | 20.77 Mn |
| Jun 30, 2023 | 18.77 Mn |
| Mar 31, 2023 | 6.71 Mn |
| Dec 31, 2022 | 4.52 Mn |
| Sep 30, 2022 | 7.30 Mn |
| Jun 30, 2022 | 7.63 Mn |
| Mar 31, 2022 | 6.52 Mn |
| Dec 31, 2021 | 7.31 Mn |
| Sep 30, 2021 | 6.62 Mn |
| Jun 30, 2021 | 7.41 Mn |